Description: Kelyniam Global, Inc. is a medical device manufacturing company. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient's computed tomography (CT) scan data, the Company's 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Company's emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. The ke72 plan provides the implants in approximately 72 hours. Its kp5day is a physical implant verification service.
Home Page: www.kelyniam.com
97 River Road
Collinsville,
CT
06019
United States
Phone:
800 280 8192
Officers
| Name | Title |
|---|---|
| Mr. Ross Bjella | Chairman & CEO |
| Mr. Terrance Kurtenbach | Chief Financial Officer |
| Michael Hamblett | Director of Investor Relations |
| Mr. James Barrow Esq. | Gen. Counsel and Director of Quality & Regulatory |
| Dr. Mark V. Smith M.D. | VP of Sales & Bus. Devel. and Director |
| Dr. Christopher Mirucki | Chief Medical Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 12.0143 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.242 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |